Complete the seven sections; the four-axis interpretation grade is computed on submit.
Who authored the report, the originating request, and key dates.
Specimen condition, clinical history, and any known cancer site.
Enter each measured serum tumour marker. Leave a field blank when the marker was not measured.
Prostate cancer; informed-choice testing.
Suspected ovarian cancer (NICE CG122 ultrasound threshold 35 IU/mL).
Pancreatic / hepatobiliary cancer (reference < 37 U/mL).
Colorectal cancer monitoring.
Hepatocellular / germ-cell tumours; a very high value suggests a germ-cell tumour.
Germ-cell / trophoblastic tumours; a very high value suggests a germ-cell tumour.
Breast cancer monitoring.
Germ-cell tumour staging; lymphoma prognosis.
Medullary thyroid carcinoma.
Neuroendocrine tumours.
Comparison with the previous value drives the monitoring / response interpretation.
Most recent previous value of the principal marker, for trend interpretation.
The narrative findings, markedly-elevated flag, and overall result status.
The summary impression, reporting category, and recommended follow-up.
Structured-reporting category label (e.g. a germ-cell-marker pattern or monitoring-trend category).
Live four-axis interpretation grade, critical-result communication, and sign-off.